News

Proactive Investor

Proteomics International Laboratories targets first commercial sales for PromarkerD in 2017

Proteomics International Laboratories (ASX:PIQ) is targeting first commercial sales at the calendar year end for PromarkerD, a world leading diagnostic test for diabetic kidney disease.

Link to article